MARKET NEWS

Copley Scientific Introduces Simple Device for Inhaled Dose Dissolution Testing
Cocrystal Pharma's Structure-Based Technology Demonstrated Broad Utility 
Oculis Announces Positive OCS-01 Phase 2 Data
BD Completes Clinical Trial for Wearable Injector
Zumutor Biologics & Catalent Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors
BeyondSpring’s Plinabulin Stimulates Both the Adaptive & Innate Immune System 

  FEATURED EDITORIAL

  COMPANY PROFILE

Integral BioSystems is a Bedford, MA-based CRO specializing in formulation development, analytical methods, scale-up, and technology transfer of ophthalmics, dermals, injectables, otics, pulmonary, sublinguals, etc. With state-of-the-art formulation and analytical equipment and expert staff, the company excels at sustained-release drug products, including injectable microspheres, liposomes, hydrogels, nano-complexes, and micro/nanocrystals. Click here for more.

  EXCLUSIVE ONLINE CONTENT

TriSalus Life Sciences & Roger Williams Medical Center Announce Initiation of Phase 1 Clinical Trial for a Novel Delivery Technology

TriSalus Life Sciences & Roger Williams Medical Center Announce Initiation of Phase 1 Clinical Trial for a Novel Delivery Technology

TriSalus Life Sciences recently announced the initiation of a new clinical trial assessing the safety and feasibility of an innovative new treatment that combines its…..

Alkahest Announces Initiation of Phase 2b Clinical Trial 

Alkahest Announces Initiation of Phase 2b Clinical Trial 

Alkahest, Inc. recently announced the initiation of a Phase 2b clinical trial of its orally administered small molecule CCR3 inhibitor, AKST4290. The company has dosed the first….

Credence MedSystems Receives Award for Best Innovation in Drug Delivery Devices

Credence MedSystems Receives Award for Best Innovation in Drug Delivery Devices

Credence MedSystems, an innovator in injectable drug delivery technology for the biopharmaceutical industry, has received the Pharmapack Award for its….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 26 – ODT/Fast Dissolve
March 4 – Transdermal/Topical Delivery